- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有36家主力机构披露2025-12-31报告期持股数据，持仓量总计4246.22万股，占流通A股14.53%
- 波段诊断：
-
技术面诊股
诊断结果：3.2技术面打败了17%的股票
技术面评分前10的股票
近期的平均成本为8.50元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为8.50元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.50","date":1781510697,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.06.16","stock":"-1.16","trade":null,"ind":"0.93"},{"date":"2026.06.15","stock":"0.12","trade":null,"ind":"3.79"},{"date":"2026.06.12","stock":"1.29","trade":null,"ind":"0.75"},{"date":"2026.06.11","stock":"-1.39","trade":null,"ind":"-0.68"},{"date":"2026.06.10","stock":"0.46","trade":null,"ind":"-2.06"},{"date":"2026.06.09","stock":"-0.92","trade":null,"ind":"3.02"},{"date":"2026.06.08","stock":"-2.36","trade":null,"ind":"-3.22"},{"date":"2026.06.05","stock":"1.14","trade":null,"ind":"-2.21"},{"date":"2026.06.04","stock":"-2.22","trade":null,"ind":"-0.27"},{"date":"2026.06.03","stock":"-1.53","trade":null,"ind":"0.73"},{"date":"2026.06.02","stock":"-1.51","trade":null,"ind":"1.63"},{"date":"2026.06.01","stock":"1.53","trade":null,"ind":"-1.51"},{"date":"2026.05.29","stock":"1.10","trade":null,"ind":"-1.81"},{"date":"2026.05.28","stock":"0.22","trade":null,"ind":"0.80"},{"date":"2026.05.27","stock":"-1.85","trade":null,"ind":"-0.88"},{"date":"2026.05.26","stock":"-2.13","trade":null,"ind":"0.12"},{"date":"2026.05.25","stock":"-0.42","trade":null,"ind":"1.66"},{"date":"2026.05.22","stock":"-0.32","trade":null,"ind":"2.30"},{"date":"2026.05.21","stock":"-3.76","trade":null,"ind":"-2.07"},{"date":"2026.05.20","stock":"-1.89","trade":null,"ind":"0.00"},{"date":"2026.05.19","stock":"0.60","trade":null,"ind":"0.26"}]
美康生物,深证成指,医疗器械指数
压力支撑
该股压力位为8.50元，支撑位为8.41元。
[{"text":"\u538b\u529b\u4f4d","value":"8.50","date":1781539200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.41","date":1781539200,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了34%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月16日 16:57
| 机构今日流向(万元) | -257.72 | 机构5日流向(万元) | -1822.05 |
| 机构10日流向(万元) | -4898.33 | 机构20日流向(万元) | -10312.25 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加85.62万股，其中基金净增仓4家，主力净增仓1家，有一定的中长期投资价值。
截止2025-12-31，共36家主力机构（基金35家，一般法人1家），持仓量总计4246.22万股，占流通A股14.53%
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 93.41万股
减仓：8家 ，减持 7.07万股
新出现在主力名单中：14家 ，持有18.97万股
从主力名单中消失：13家 ，原持有19.69万股
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 93.41万股
减仓：8家 ，减持 7.07万股
新出现在主力名单中：14家 ，持有18.97万股
从主力名单中消失：13家 ，原持有19.69万股
消息面诊股
诊断结果：5.9消息面打败了29%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 美康生物：全资子公司取得离子阱质谱仪医疗器械注册证
2026-06-12 - 第三代TSH检测新突破，领航甲状腺精准诊断新标准
2026-06-12 - 精准质谱检测，守护女性远离多囊困扰
2026-06-09 - 美康生物2025年全年每10股派0.33元 股权
2026-06-04 - 美康生物：公司主要从事体外诊断产品的研发、生产和销
2026-05-12 - 体外诊断产品与诊断服务协同发力 美康生物Q1扣非净
2026-04-29 - 美康生物：公司聚焦中东东南亚南美等战略市场
2026-04-29 - 股东追踪|李志军新进美康生物前十大流通股东
2026-04-28 - 美康生物（截止2026年3月31日）股东人数为23
2026-04-28 - 美康生物：第一季度净利润3376.64万元，同比增
2026-04-28
消息列表
| 一般消息 | 募资投向 | 2026-06-01 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-29 |
| 利好 | 分红转增 | 10派0.33元(含税) | 2026-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-14 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-14 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了2%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.06.16","price":"0.93","value":null},{"date":"2026.06.15","price":"3.79","value":null},{"date":"2026.06.12","price":"0.75","value":null},{"date":"2026.06.11","price":"-0.68","value":null},{"date":"2026.06.10","price":"-2.06","value":null},{"date":"2026.06.09","price":"3.02","value":null},{"date":"2026.06.08","price":"-3.22","value":null},{"date":"2026.06.05","price":"-2.21","value":null},{"date":"2026.06.04","price":"-0.27","value":null},{"date":"2026.06.03","price":"0.73","value":null},{"date":"2026.06.02","price":"1.63","value":null},{"date":"2026.06.01","price":"-1.51","value":null},{"date":"2026.05.29","price":"-1.81","value":null},{"date":"2026.05.28","price":"0.80","value":null},{"date":"2026.05.27","price":"-0.88","value":null},{"date":"2026.05.26","price":"0.12","value":null},{"date":"2026.05.25","price":"1.66","value":null},{"date":"2026.05.22","price":"2.30","value":null},{"date":"2026.05.21","price":"-2.07","value":null},{"date":"2026.05.20","price":"0.00","value":null},{"date":"2026.05.19","price":"0.26","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 力诺药包 | 58.26% | 18.28% | 5.9分 |
| 2 | 正川股份 | 20.94% | 5.71% | 6.5分 |
| 3 | 华兰股份 | 15.40% | 0.47% | 5.2分 |
| 4 | 万孚生物 | 14.85% | 1.37% | 4.6分 |
| 5 | 山东药玻 | 8.31% | 1.02% | 5.2分 |
| 6 | 奕瑞科技 | 6.91% | -2.37% | 5.7分 |
| 8 | 大博医疗 | 3.61% | 1.95% | 5.6分 |
| 10 | 麦澜德 | -1.37% | -3.60% | 5.2分 |
| 12 | 九安医疗 | -1.91% | 4.73% | 5.1分 |
| 14 | 赛诺医疗 | -3.73% | 2.54% | 4.7分 |
| 16 | 博拓生物 | -3.84% | 7.13% | 4.8分 |
| 18 | 三鑫医疗 | -4.34% | 3.93% | 4.6分 |
| 20 | 安图生物 | -5.12% | 5.99% | 4.7分 |
| 22 | 九强生物 | -5.46% | 1.22% | 4.9分 |
| 24 | 仁度生物 | -5.66% | 1.19% | 5.3分 |
| 26 | 海泰新光 | -6.34% | -4.12% | 5.3分 |
| 28 | - | -6.45% | 0.65% | 分 |
| 30 | 康德莱 | -7.06% | 2.40% | 4.9分 |
| 32 | 振德医疗 | -7.25% | 7.83% | 5.9分 |
| 34 | 新华医疗 | -7.58% | -2.20% | 4.6分 |
| 36 | 华大智造 | -8.26% | 3.66% | 5.5分 |
| 38 | 东星医疗 | -8.68% | -3.63% | 4.4分 |
| 40 | 迈瑞医疗 | -8.74% | 0.40% | 4.3分 |
| 42 | 国发股份 | -9.05% | -0.84% | 4.4分 |
| 44 | 奥泰生物 | -9.89% | -5.37% | 3.6分 |
| 46 | 东富龙 | -10.15% | 3.66% | 4.9分 |
| 48 | 祥生医疗 | -10.51% | 0.13% | 5.1分 |
| 50 | 瑞迈特 | -10.81% | -5.12% | 4.7分 |
| 52 | 微电生理 | -11.85% | 3.75% | 5.2分 |
| 54 | - | -11.98% | -2.38% | 分 |
| 56 | 普门科技 | -12.07% | -2.18% | 5.0分 |
| 58 | 伟思医疗 | -12.33% | 6.65% | 5.4分 |
| 60 | 康泰医学 | -12.37% | 0.56% | 4.2分 |
| 62 | 维力医疗 | -12.43% | 1.82% | 4.8分 |
| 64 | 天臣医疗 | -12.65% | 0.84% | 4.9分 |
| 66 | 戴维医疗 | -12.96% | 0.20% | 4.2分 |
| 68 | 宝莱特 | -13.11% | 9.88% | 4.8分 |
| 70 | 南微医学 | -13.23% | -1.12% | 4.8分 |
| 72 | 三诺生物 | -13.52% | 1.03% | 4.8分 |
| 74 | 南卫股份 | -13.76% | -6.74% | 5.6分 |
| 76 | 开立医疗 | -13.98% | 2.11% | 3.9分 |
| 78 | 昊海生科 | -14.34% | -1.83% | 4.4分 |
| 80 | - | -14.58% | -6.38% | 分 |
| 82 | 基蛋生物 | -14.73% | 0.24% | 4.6分 |
| 84 | 采纳股份 | -14.96% | -2.68% | 4.7分 |
| 86 | 东方生物 | -15.07% | -0.96% | 4.2分 |
| 88 | 济高发展 | -15.10% | -4.17% | 4.3分 |
| 90 | 硕世生物 | -15.22% | 7.99% | 4.3分 |
| 92 | *ST海利 | -15.36% | -3.98% | 3.5分 |
| 94 | 济民健康 | -15.93% | -2.68% | 4.1分 |
| 96 | 易瑞生物 | -16.15% | -1.41% | 4.1分 |
| 98 | 洁特生物 | -16.48% | 3.72% | 3.9分 |
| 100 | 冠昊生物 | -16.80% | -0.18% | 4.2分 |
| 102 | 蓝帆医疗 | -17.19% | -7.11% | 4.5分 |
| 104 | 华强科技 | -17.31% | 0.18% | 4.1分 |
| 106 | 爱博医疗 | -17.34% | 0.10% | 4.2分 |
| 108 | 中源协和 | -17.48% | -1.64% | 4.7分 |
| 110 | 之江生物 | -17.85% | -4.91% | 4.2分 |
| 112 | 透景生命 | -18.12% | -0.62% | 4.1分 |
| 114 | 奥美医疗 | -18.49% | 1.21% | 4.8分 |
| 116 | 海尔生物 | -19.06% | -2.52% | 5.2分 |
| 118 | 达安基因 | -19.43% | -6.47% | 4.5分 |
| 120 | 澳华内镜 | -19.45% | -1.86% | 4.8分 |
| 122 | 拱东医疗 | -20.12% | -1.52% | 5.1分 |
| 124 | 安必平 | -20.70% | -1.36% | 4.1分 |
| 126 | 奥精医疗 | -21.41% | -2.79% | 3.8分 |
| 128 | 阳普医疗 | -22.18% | -3.35% | 4.6分 |
| 130 | 睿昂基因 | -22.58% | -3.83% | 3.9分 |
| 132 | 北芯生命 | -23.67% | -2.05% | 5.4分 |
| 134 | 爱朋医疗 | -24.33% | -0.71% | 4.2分 |
| 136 | - | -26.41% | -8.93% | 分 |
| 138 | 三友医疗 | -26.96% | -3.17% | 4.3分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/243 ， 94/243。
[{"date":"2026-03-31","value":"1.14","vol":"1.15"},{"date":"2025-12-31","value":"2.14","vol":"2.66"},{"date":"2025-09-30","value":"2.05","vol":"2.97"},{"date":"2025-06-30","value":"1.93","vol":"2.34"},{"date":"2025-03-31","value":"1.03","vol":"1.15"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.14 | 2.14 | 2.05 | 1.93 | 1.03 |
| 行业(%) | 1.15 | 2.66 | 2.97 | 2.34 | 1.15 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"38.45","vol":"52.18"},{"date":"2025-12-31","value":"36.80","vol":"51.61"},{"date":"2025-09-30","value":"39.64","vol":"51.74"},{"date":"2025-06-30","value":"40.80","vol":"52.05"},{"date":"2025-03-31","value":"39.75","vol":"51.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
38.45 | 36.80 | 39.64 | 40.80 | 39.75 |
| 行业(%) | 52.18 | 51.61 | 51.74 | 52.05 | 51.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 74/243 ， 50/243。
[{"date":"2026-03-31","value":"0.53","vol":"5.49"},{"date":"2025-12-31","value":"-11.67","vol":"1.44"},{"date":"2025-09-30","value":"-19.27","vol":"0.26"},{"date":"2025-06-30","value":"-22.43","vol":"-1.09"},{"date":"2025-03-31","value":"-22.32","vol":"-0.12"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.53 | -11.67 | -19.27 | -22.43 | -22.32 |
| 行业(%) | 5.49 | 1.44 | 0.26 | -1.09 | -0.12 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"11.08","vol":"-16.14"},{"date":"2025-12-31","value":"-75.50","vol":"-25.45"},{"date":"2025-09-30","value":"-73.02","vol":"-15.37"},{"date":"2025-06-30","value":"-68.15","vol":"-18.14"},{"date":"2025-03-31","value":"-61.57","vol":"-2.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
11.08 | -75.50 | -73.02 | -68.15 | -61.57 |
| 行业(%) | -16.14 | -25.45 | -15.37 | -18.14 | -2.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 33/243 ， 17/243。
[{"date":"2026-03-31","value":"0.10","vol":"0.08"},{"date":"2025-12-31","value":"0.42","vol":"0.35"},{"date":"2025-09-30","value":"0.31","vol":"0.25"},{"date":"2025-06-30","value":"0.20","vol":"0.17"},{"date":"2025-03-31","value":"0.10","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.42 | 0.31 | 0.20 | 0.10 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.96","vol":"0.55"},{"date":"2025-12-31","value":"3.76","vol":"2.33"},{"date":"2025-09-30","value":"2.54","vol":"1.66"},{"date":"2025-06-30","value":"1.60","vol":"1.12"},{"date":"2025-03-31","value":"0.81","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.96 | 3.76 | 2.54 | 1.60 | 0.81 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-15.38","vol":"0.09"},{"date":"2025-12-31","value":"30.15","vol":"32.02"},{"date":"2025-09-30","value":"12.19","vol":"14.74"},{"date":"2025-06-30","value":"39.36","vol":"15.54"},{"date":"2025-03-31","value":"-12.37","vol":"4.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -15.38 | 30.15 | 12.19 | 39.36 | -12.37 |
| 行业 | 0.09 | 32.02 | 14.74 | 15.54 | 4.16 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.03","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.68","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.03 | - | 0.68 | - |
| 行业 | 0.00 | 1.59 | 0.01 | 1.57 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 53/243 ， 59/243。
[{"date":"2026-03-31","value":"3.46","vol":"6.20"},{"date":"2025-12-31","value":"3.03","vol":"5.29"},{"date":"2025-09-30","value":"3.12","vol":"5.66"},{"date":"2025-06-30","value":"3.07","vol":"5.47"},{"date":"2025-03-31","value":"3.29","vol":"5.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.46 | 3.03 | 3.12 | 3.07 | 3.29 |
| 行业 | 6.20 | 5.29 | 5.66 | 5.47 | 5.80 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.71","vol":"5.06"},{"date":"2025-12-31","value":"2.43","vol":"4.14"},{"date":"2025-09-30","value":"2.46","vol":"4.51"},{"date":"2025-06-30","value":"2.38","vol":"4.35"},{"date":"2025-03-31","value":"2.61","vol":"4.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.71 | 2.43 | 2.46 | 2.38 | 2.61 |
| 行业 | 5.06 | 4.14 | 4.51 | 4.35 | 4.69 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 69/243 ， 70/243。
[{"date":"2026-03-31","value":"17.05","vol":"21.96"},{"date":"2025-12-31","value":"19.32","vol":"22.90"},{"date":"2025-09-30","value":"19.34","vol":"22.07"},{"date":"2025-06-30","value":"19.42","vol":"22.01"},{"date":"2025-03-31","value":"17.41","vol":"21.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.05 | 19.32 | 19.34 | 19.42 | 17.41 |
| 行业(%) | 21.96 | 22.90 | 22.07 | 22.01 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.21","vol":"0.39"},{"date":"2025-12-31","value":"0.24","vol":"0.40"},{"date":"2025-09-30","value":"0.24","vol":"0.71"},{"date":"2025-06-30","value":"0.24","vol":"0.58"},{"date":"2025-03-31","value":"0.21","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.21 | 0.24 | 0.24 | 0.24 | 0.21 |
| 行业(%) | 0.39 | 0.40 | 0.71 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.99","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.57","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.58","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.63","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]